Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Silvia Sabatino
ResearcherPublications, citations & collaboration network
Silvia Sabatino is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 36 works, 302 citations, an h-index of 5 and an i10-index of 2.
36
Works
302
Citations
5
h-index
2
i10-index
IDs:OpenAlex
How has Silvia Sabatino's publication output changed over time?
ScholarIQpublication output · 2020–2025
Output grew300% over the shown period — from 1 works in 2020 to 4 in 2025.
1
1
4
1
4
20202021202320242025
What are the most-cited papers on Silvia Sabatino?
ScholarIQmost cited works
GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy
Pierre‐Benoit Ancey, Caroline Contat, Gaël Boivin, Silvia Sabatino, Justine Pascual, Nadine Zangger, Jean Yannis Perentes, Solange Peters, E. Dale Abel, David G. Kirsch, Jeffrey C. Rathmell, Marie‐Catherine Vozenin, Etienne Meylan
Cancer Research. 2021227 CitationsOPEN ACCESS
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth
Caroline Contat, Pierre‐Benoit Ancey, Nadine Zangger, Silvia Sabatino, Justine Pascual, Stéphane Escrig, Louise Helene Søgaard Jensen, Christine Goepfert, Bernard Lanz, Mario Lepore, Rolf Gruetter, A. Rossier, Sabina Berezowska, Christina Neppl, Inti Zlobec, Stéphanie Clerc-Rosset, Graham Knott, Jeffrey C. Rathmell, E. Dale Abel, Anders Meibom, Etienne Meylan
S1336409049. 202031 CitationsOPEN ACCESS
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)
Andrea Chiricozzi, Matteo Megna, Alessandro Giunta, Carlo Giovanni Carrera, Paolo Dapavo, Anna Balato, Piergiorgio Malagoli, Stella Mazzoccoli, Aurora Parodi, Silvia Sabatino, Carlotta Buzzoni, Chu-Han Huang, Alessandra Narcisi
S21432770. 20238 CitationsOPEN ACCESS
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch
J.M. Carrascosa, Alessandra Narcisi, Toshifumi Nomura, Sonja Ständer, Christian Vestergaard, Silvia Sabatino, Susanne Grond, Uffe Koppelhus, Mohamed Elrayes, Yun-Fei Chen, Chunyuan Liu, Andreas Wollenberg
Dermatology and Therapy. 20248 CitationsOPEN ACCESS
Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO)
Massimo Travaglini, Julia‐Tatjana Maul, Christian Kors, Shirin Zaheri, Jens Gerwien, Michaela Müller, Alan Brnabic, Silvia Sabatino, Christopher Schuster, Tsen‐Fang Tsai
S73516063. 20236 CitationsOPEN ACCESS
Related on ScholarIQ
Eli Lilly (United States)
Institution
GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy
Paper
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth
Paper
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)
Paper
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch
Paper
Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO)
Paper